4DMedical Limited (ASX:4DX) Directors Insider Transactions



The Directors and Chief Executives of 4DMedical Limited (ASX:4DX) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the 4DMedical Limited's shares in the stock market. Below table shows the list of insider transactions as reported by 4DMedical Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

4DMedical Limited Directors/Insider Transactions Activity

List of Insider trades activity from 4DMedical Limited (4DX).

Date Director Director's Title Shares Value Note
21 Jan 2026 Fouras (Andreas) Chief Executive Officer 1,587,757 - -
21 Jan 2026 Sutton (Julian) Director (Non-Executive) 2,000,000 - -
15 Jan 2025 Bianchi (Lilian) Non Executive Chairman 196,906 - -
15 Jan 2025 Livingston (John Andrew) Director (Executive) 60,147 - -
15 Jan 2025 Sutton (Julian) Director (Non-Executive) 60,147 - -
14 Jan 2025 Figlin (Robert Alan) Director (Non-Executive) 60,147 - -
14 Jan 2025 Mcginty (Geraldine Bernadette) Director (Non-Executive) 137,787 - -